maybe you need to do some DD? GENT drugs are approved in the EU only. Phase # here in the USA. SO the best is on the horizon. Never heard of JAZZ before 18 months ago. And would never had bought a pharma named "JAZZ" until I did my DD.
GL2U..sounds like you will need some.
if you look at GENTs chart you will see it was $7 in july of this year so I would say in Italy the word was out a long time ago and all the relatives bought. They may not have the insider rules we do but my bet is that jazz has been looking at it since july and was waiting fro europe approval on the drug and had already cut a price much earlier. Gents earnings next year are estimated to almost quadruple from this years and that is with Italian taxes but they will become a Irish company now. The press release said it would be earnings accretive next year and the stock imo has gone up for several reasons
1) earnings accretive
2) the drug will eventually be approved in the USA
3) this gives Jazz more drugs in its arsenal so they aren't relying on one drug which will help expand the multiple people are willing to pay
4) other drugs in GENT pipeline potential
This will be another good add on as was the one earlier this year.